ESTRO24: GE HealthCare to Reveal AI-Driven, Personalized Oncology Solutions

GE HealthCare has revealed Revolution RT, a new radiation therapy CT solution with hardware and software solutions that increase imaging accuracy and simplify simulation workflow for a more personalized, seamless oncology care pathway experience.
 
Revolution RT is being unveiled at this year’s European Society for Therapeutic Radiology and Oncology (ESTRO) 2024 Congress in Glasgow, along with an updated, artificial intelligence (AI)-enhanced version of the company’s Intelligent Radiation Therapy (iRT) platform.
 
“At GE HealthCare, we are committed to advancing the frontiers of oncology treatment through AI-driven technologies that transform and optimize the care continuum,” said Dr. Taha Kass-Hout, chief technology and science officer of GE HealthCare. “Our showcase at ESTRO this year highlights innovations that will allow clinicians to view the patient’s anatomy with great accuracy, helping facilitate precise tumor targeting while aiming to protect nearby healthy tissue. By integrating these capabilities into our systems, we create a precise, more connected, and efficient care environment that accelerates the delivery of personalized and timely care, with the goal of enabling better patient outcomes. This comprehensive approach empowers clinicians around the globe to tackle the most challenging disease states with precision and efficiency.”

Revolution RT

The new CT simulator features a wide-bore CT platform and high-performance radiation therapy simulation, diagnostic, and interventional capabilities. Its precision radiotherapy simulation aims to enable more accurate imaging, boost workflow and efficiency, and use deep learning to help image the patient more accurately.

Updated Intelligent Radiation Therapy (iRT)

The updated iRT includes an integrated workflow that connects various applications into a single interface, multi-vendor interoperability, seamless data transfer and automation, and a catalog of RT applications from GE HealthCare and third parties:

• MR Direct, with Spectronic Medical, uses AI to convert MR simulation images into an equivalent CT image for RT dose calculation.
• Simplified planning, with recently acquired MIM Software, has automated context launching to simplify pre-treatment planning steps including image viewing, segmentation, and fusion.
• InstaPlan, with RaySearch, is a novel way to create treatment plans while the patient is still on the simulation table. The shift could reduce the time between simulation and first radiation dose.

 
“The key to better patient outcomes in oncology care requires solutions that simplify and shorten an incredibly complex workflow for providers, as well as personalize the care pathway for patients, in order to ensure more effective care for each individual,” said Dr. Ben Newton, general manager, Oncology at GE HealthCare. “GE HealthCare worked closely with clinicians globally to develop the iRT platform which streamlines the radiation therapy pathway by connecting disparate multi-vendor application systems, creating a vendor-agnostic ecosystem and harnessing the power of AI to potentially reduce the critical time between treatment planning and first treatment.”